Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Phase II, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Response Study of an Aqueous Topical Formulation of Nitroglycerin, IMX-150, in the Treatment of Pain in Diabetic Peripheral Neuropathy of the Feet

NCT00641953 is registered in ClinicalTrials.gov with Procris Pharmaceuticals as lead sponsor.

NCT NCT00641953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00641953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Phase II, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Response Study of an Aqueous Topical Formulation of Nitroglycerin, IMX-150, in the Treatment of Pain in Diabetic Peripheral Neuropathy of the Feet
Lead sponsor
Procris Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
March 31, 2008
Enrollment
155 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathy